Behavior of primary human osteoblasts on trimmed and sandblasted Ti6Al4V surfaces functionalized with integrin avb3-selective cyclic RGD peptides

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 1, 2013, Pages 87-97

  Mas Moruno, Carlos ^a   Dorfner, Petra M ^b   Manzenrieder, Florian ^a   Neubauer, Stefanie ^a   Reuning, Ute ^c   Burgkart, Rainer ^b   Kessler, Horst ^a,d  

^a Munich Center for Integrated Protein Science   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Osteoblast adhesion; RGD peptide; Roughness; Surface coating; Surface treatment; Ti6Al4V

Indexed keywords

ATTACHMENT EFFICIENCY; CELL BEHAVIORS; CELL MORPHOLOGY; CELL-ADHESIVES; ENHANCING EFFECT; EXTRACELLULAR MATRIX PROTEIN; FUNCTIONALIZATIONS; FUNCTIONALIZED; IMPLANT MATERIALS; INTEGRIN-BINDING MOTIFS; INTEGRINS; OSSEOINTEGRATION; OSTEOBLAST ADHESION; PRIMARY HUMAN OSTEOBLASTS; RGD PEPTIDE; SANDBLASTED SURFACES; SURFACE COATINGS; TI-6AL-4V; TRIMMED SURFACES;

ADHESION; BEHAVIORAL RESEARCH; CELL CULTURE; COATINGS; MORPHOLOGY; PEPTIDES; SURFACE PROPERTIES; SURFACE ROUGHNESS; SURFACE TREATMENT;

OSTEOBLASTS;

ARGINYLGLYCYLASPARTIC ACID; BIOMATERIAL; CYCLOPEPTIDE; SANDBLASTED TITANIUM ALUMINUM VANADIUM DISK; TRIMMED TITANIUM ALUMINUM VANADIUM DISK; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; BONE REGENERATION; CELL ADHESION; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; ISOTOPE LABELING; MATERIAL COATING; OSTEOBLAST; PROTEIN FUNCTION; SCANNING ELECTRON MICROSCOPY; TOPOGRAPHY;

BIOLOGICAL MARKERS; BONE AND BONES; CELL ADHESION; CELL COUNT; CELL SHAPE; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; OSTEOBLASTS; PEPTIDES, CYCLIC; PROTEIN BINDING; SURFACE PROPERTIES; TITANIUM;

EID: 84872675807     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34303     Document Type: Article

References (54)

1. Siebers MC, ter Brugge PJ, Walboomers XF, Jansen JA. Integrins as a linker protein between osteoblasts and bone replacing materials. A critical review. Biomaterials 2005;26:137-146.
2. Shekaran A, Garcia AJ. Extracellular matrix-mimetic adhesive biomaterials for bone repair. J Biomed Mater Res A 2011;96:261-272.
3. Lopez-García M, Kessler H. Stimulation of bone growth on implants by integrin ligands. In: Epple M, Bauerlein E, editors. Handbook of Biomineralization. Weinheim: Wiley, 2007. p. 109-126.
4. Hersel U, Dahmen C, Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003;24:4385-4415.
5. Bellis SL. Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials 2011;32:4205-4210.
6. Chung EH, Gilbert M, Virdi AS, Sena K, Sumner DR, Healy KE. Biomimetic artificial ECMs stimulate bone regeneration. J Biomed Mater Res A 2006;79:815-826.
7. Kantlehner M, Finsinger D, Meyer J, Schaffner P, Jonczyk A, Diefenbach B, et al. Selective RGD-mediated adhesion of osteoblasts at surfaces of implants. Angew Chem Int Ed 1999;38:560-562.
8. Kantlehner M, Schaffner P, Finsinger D, Meyer J, Jonczyk A, Diefenbach B, et al. Surface coating with cyclic RGD peptides stimuates osteoblast adhesion and proliferation as well as bone formation. ChemBioChem 2000;1:107-114.
9. Auernheimer J, Zukowski D, Dahmen C, Kantlehner M, Enderle A, Goodman SL, et al. Titanium implant materials with improved biocompatibility via coating with cyclic RGD-peptides via phosphonates. ChemBioChem 2005;6:2034-2040.
10. Magdolen U, Auernheimer J, Dahmen C, Schauwecker J, Gollwitzer H, Tü bel J, et al. Growth promoting in vitro effect of synthetic cyclic RGD-peptides on human osteoblast-like cells attached to cancellous bone. Int J Mol Med 2006;17:1017-1021.
11. Elmengaard B, Bechtold JE, Soballe K. In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants. Biomaterials 2005;26:3521-3526.
12. Kroese-Deutman HC, Van den Dolder J, Spauwen PHM, Jansen JA. Influence of RGD-loaded titanium implants on bone formation in vivo. Tissue Eng 2005;11:1867-1875.
13. Elmengaard B, Bechtold JE, Søballe K. In vivo effects of RGDcoated titanium implants inserted in two bone-gap models. J Biomed Mater Res A 2005;75:249-255.
14. Brunette DM, Tengvall P, Textor M, Thomsen P, editors. Titanium in Medicine. Berlin: Springer-Verlag, 2001.
15. Martin JY, Schwartz Z, Hummert TW, Schraub DM, Simpson J, Lankford J, et al. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblastlike cells (MG63). J Biomed Mater Res 1995;29:389-401.
16. Matschegewski C, Staehlke S, Loeffler R, Lange R, Chai F, Kern DP, et al. Cell architecture-cell function dependencies on titanium arrays with regular geometry. Biomaterials 2010;31:5729-5740.
17. Richert L, Vetrone F, Yi JH, Zalzal SF, Wuest JD, Rosei F, et al. Surface nanopatterning to control cell growth. Adv Mater 2008;20:1488-1492.
18. Anselme K. Biomaterials and interface with bone. Osteoporos Int 2011;22:2037-2042.
19. Anselme K. Bigerelle M, Noel B, Dufresne E, Judas D, Iost A, et al. Qualitative and quantitative study of human osteoblast adhesion on materials with various surface roughnesses. J Biomed Mater Res 2000;49:155-166.
20. Anselme K, Linez P, Bigerelle M, Le Maguer D, Le Maguer A, Hardouin P, et al. The relative influence of the topography and chemistry of TiAl6V4 surfaces on osteoblastic cell behaviour. Biomaterials 2000;21:1567-1577.
21. Lü then F, Lange R, Becker P, Rychly J, Beck U, Nebe, JGB. The influence of surface roughness of titanium on b1- and b3-integrin adhesion and the organization of fibronectin in human osteoblastic cells. Biomaterials 2005;26:2423-2440.
22. ter Brugge PJ, Jansen JA. Initial interaction of rat bone marrow cells with non-coated and calcium phosphate coated titanium substrates. Biomaterials 2002;23:3269-3277.
23. Schwartz Z, Lohmann CH, Oefinger J, Bonewald LF, Dean DD, Boyan BD. Implant surface characteristics modulate differentiation behavior of cells in the osteoblastic lineage. Adv Dent Res 1999;13:38-48.
24. Lincks J, Boyan BD, Blanchard CR, Lohmann CH, Liu Y, Cochran DL, et al. Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 1998;19:2219-2232.
25. Deligianni DD, Katsala N, Ladas S, Sotiropoulou D, Amedee J, Missirlis YF. Effect of surface roughness of the titanium alloy Ti- 6Al-4V on human bone marrow cell response and on protein adsorption. Biomaterials 2001;22:1241-1251.
26. Anselme K, Bigerell M. Modelling approach in cell/material interactions studies. Biomaterials 2006;27:1187-1199.
27. Bagno A, Piovan A, Dettin M, Brun P, Gambaretto R, Di Bello C, et al. Improvement of Anselme's adhesion model for evaluating human osteoblast response to peptide-grafted titanium surfaces. Bone 2007;41/4:704-712.
28. Lange R, Luethen F, Nebe B, Rychly J, Beck U. Mathematical correlation between biomaterial and cellular parameters - A critical reflection. Biomol Eng 2007;24:526-530.
29. Giljean S, Ponche A, Bigerelle M, Anselme K. Statistical approach of chemistry and topography effect on human osteoblast adhesion J Biomed Mater Res A 2010;94:1111-1123.
30. Arnold M, Cavalcanti-Adam EA, Glass R, Blümmel J, Eck W, Kantlehner M, et al. Activation of integrin function by nanopatterned adhesive interfaces. ChemPhysChem 2004;5:383-388.
31. Cavalcanti-Adam EA, Volberg T, Micoulet A, Kessler H, Geiger B, Spatz JP. Cell spreading and focal adhesion dynamics are regulated by spacing of integrin ligands. Biophys J 2007;92:2964-2974.
32. Huang J, Gräter SV, Corbellini F, Rinck S, Bock E, Kemkemer R, et al. Impact of order and disorder in RGD nanopatterns on cell adhesion. Nano Lett 2009;9:1111-1116.
33. Houseman BT, Mrksich M. The microenvironment of immobilized Arg-Gly-Asp peptides is an important determinant of cell adhesion. Biomaterials 2001;22:943-955.
34. Liu B, Liu Y, Riesberg JJ, Shen W. Dynamic presentation of immobilized ligands regulated through biomolecular recognition. J Am Chem Soc 2010;132:13630-13632.
35. 2. Langmuir 2004;20:2270-2273.
36. Haubner R, Gratias R, Diefenbach B, Goodman SL, Jonczyk A, Kessler H. Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin avb3 antagonists. J Am Chem Soc 1996;118:7461-7472.
37. Aumailley M, Gurrath M, Müller G, Calvete J, Timpl R, Kessler H. Arg-Gly-Asp constrained within cyclic peptides: Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett 1991;291:50-54.
38. Dechantsreiter MA, Planker E, Mathä B, Lohof E, Hölzemann G, Jonczyk A, et al. N-Methylated cyclic RGD peptides as highly active and selective avb3 integrin antagonists. J Med Chem 1999; 42:3033-3040.
39. Mas-Moruno C, Rechenmacher F, Kessler H. Cilengitide: The first anti-angiogenic small molecule drug candidate. Design, synthesis and clinical evaluation. Anti-Cancer Agents Med Chem 2010;10: 753-768.
40. Auernheimer J, Haubner R, Schottelius M, Wester HJ, Kessler H. Radio-analytical determination of the coating efficiency of cyclic RGD peptides. Helv Chim Acta 2006;89:833-840.
41. Jones SJ, Boyde A. The migration of osteoblasts. Cell Tiss Res 1977;184:179-193.
42. Landegren U. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 1984; 67:379-388.
43. Bodine PVN, Komm BS. Evidence that conditionally immortalized human osteoblasts express an osteocalcin receptor. Bone 1999; 25:535-543.
44. Grzesik WJ, Robey PG. Bone matrix RGD glycoproteins immunolocalization and interaction with primary osteoblastic bone cells in vitro. J Bone Miner Res 1994;9:487-496.
45. Schneider G, Burridge K. Formation of focal adhesions by osteoblasts adhering to different substrata. Exp Cell Res 1994;214: 264-269.
46. Sinha RK, Tuan RS. Regulation of human osteoblast integrin expression by orthopedic implant materials. Bone 1996;18:451-457.
47. Dahmen C, Auernheimer J, Meyer A, Enderle A, Goodman SL, Kessler H. Improving implant materials by coating with nonpeptidic, highly specific integrin ligands. Angew Chem Int Ed 2004;43: 6649-6652.
48. Auernheimer J, Kessler H. Benzylprotected aromatic phosphonic acids for anchoring peptides on titanium. Bioorg Med Chem Lett 2006;16:271-273.
49. Gnauck M, Jaehne E, Blaettler T, Tosatti S, Textor M, Adler, HJP. Carboxy-terminated oligo(ethylene glycol)-alkane phosphate: Synthesis and self-assembly on titanium oxide surfaces. Langmuir 2007;23:377-381.
50. Ter Brugge PJ, Dieudonne S, Jansen JA. Initial interaction of U2OS cells with noncoated and calcium phosphate coated titanium substrates. J Biomed Mater Res 2002;5:399-407.
51. Schuler M, Owen GR, Hamilton DW, de Wild M, Textor M, Brunette DM, et al. Biomimetic modification of titanium dental implant model surfaces using the RGDSP-peptide sequence: A cell morphology study. Biomaterials 2006;27:4003-4015.
52. Harbers GM, Healy KE. The effect of ligand type and density on osteoblast adhesion, proliferation, and matrix mineralization. J Biomed Mater Res A 2005;75:855-869.
53. Pegueroles M, Aparicio C, Bosio M, Engel E, Gil FJ, Planell JA, et al. Spatial organization of osteoblast fibronectin matrix on titanium surfaces: effects of roughness, chemical heterogeneity and surface energy. Acta Biomater 2010;6:291-301.
54. Dettin M, Bagno A, Gambaretto R, Iucci G, Conconi MT, Tuccitto N, et al. Covalent surface modification of titanium oxide with different adhesive peptides: surface characterization and osteoblastlike cell adhesion. J Biomed Mater Res A 2009;90:35-45.